The addition of pegylated liposomal doxorubicin to bortezomib did not improve overall in relapsed/refractory multiple myeloma.
...
20 mayo 2016
Myeloma Multiple : Adding Liposomal Doxorubicin to Bortezomib Fails to Improve Survival .
Jason Hoffman, PharmD, RPh /// May 19, 2016 .
The addition of pegylated liposomal doxorubicin to bortezomib did not improve overall in relapsed/refractory multiple myeloma.
...
The addition of pegylated liposomal doxorubicin to bortezomib did not improve overall in relapsed/refractory multiple myeloma.
...